Taylor M Coe1, Katherine E Fero1, Paul T Fanta1,2, Robert J Mallory3, Chih-Min Tang3, James D Murphy1,4, Jason K Sicklick5,6. 1. School of Medicine, University of California, La Jolla, CA, USA. 2. Division of Hematology and Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. 3. Division of Surgical Oncology and Department of Surgery, Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, Mail Code 0987, La Jolla, CA, 92093-0987, USA. 4. Department of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. 5. School of Medicine, University of California, La Jolla, CA, USA. jsicklick@ucsd.edu. 6. Division of Surgical Oncology and Department of Surgery, Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, Mail Code 0987, La Jolla, CA, 92093-0987, USA. jsicklick@ucsd.edu.
Abstract
BACKGROUND AND AIMS: Gastrointestinal stromal tumors (GISTs) have significant variability in size and malignant behavior. Our current understanding is limited to pathological analyses, autopsy studies, and small case series. The aim of the current study is to define the risk factors, incidence, and mortality rates of GIST <2 cm in the National Cancer Institute's Surveillance, Epidemiology, and End Results database. METHODS: Patients with histologically confirmed malignant GIST <2 cm were studied from 2001 to 2011. GIST was defined by GI tumor site codes and GIST-specific histology codes. RESULTS: We identified 378 patients with GIST <2 cm. The average age at diagnosis was 64.0 years with equal sex distribution. The most common tumor location was the stomach (62.2 %), followed by the small intestine (23.3 %), colon (5.6 %), and rectum (3.4 %). Most patients had localized disease (79.4 %), but 11.4 % had regional/distant metastatic disease. The annual incidence rate was 4.2 per 10,000,000 (10M). This was the highest among Blacks (7.6 per 10M). Among patients with GIST and no additional cancers, the 5-year GIST-specific mortality was 12.9 %. Moreover, there was a significantly increased 5-year GIST-specific mortality in those patients who had regionally advanced (34.0 %) or metastatic GIST (34.3 %), as compared to those patients with localized GIST (5.6 %). CONCLUSIONS: This study represents the first population-based analysis of malignant GIST <2 cm. While quite rare, these tumors have an underappreciated disease-specific mortality. Further studies are needed to define the underlying reasons for the identified racial differences, to develop novel risk assessment schema for patients with these small tumors, and to determine appropriate indications for resection and/or medical therapy.
BACKGROUND AND AIMS: Gastrointestinal stromal tumors (GISTs) have significant variability in size and malignant behavior. Our current understanding is limited to pathological analyses, autopsy studies, and small case series. The aim of the current study is to define the risk factors, incidence, and mortality rates of GIST <2 cm in the National Cancer Institute's Surveillance, Epidemiology, and End Results database. METHODS:Patients with histologically confirmed malignant GIST <2 cm were studied from 2001 to 2011. GIST was defined by GI tumor site codes and GIST-specific histology codes. RESULTS: We identified 378 patients with GIST <2 cm. The average age at diagnosis was 64.0 years with equal sex distribution. The most common tumor location was the stomach (62.2 %), followed by the small intestine (23.3 %), colon (5.6 %), and rectum (3.4 %). Most patients had localized disease (79.4 %), but 11.4 % had regional/distant metastatic disease. The annual incidence rate was 4.2 per 10,000,000 (10M). This was the highest among Blacks (7.6 per 10M). Among patients with GIST and no additional cancers, the 5-year GIST-specific mortality was 12.9 %. Moreover, there was a significantly increased 5-year GIST-specific mortality in those patients who had regionally advanced (34.0 %) or metastatic GIST (34.3 %), as compared to those patients with localized GIST (5.6 %). CONCLUSIONS: This study represents the first population-based analysis of malignant GIST <2 cm. While quite rare, these tumors have an underappreciated disease-specific mortality. Further studies are needed to define the underlying reasons for the identified racial differences, to develop novel risk assessment schema for patients with these small tumors, and to determine appropriate indications for resection and/or medical therapy.
Entities:
Keywords:
GIST tumorlet; ICC hyperplasia; Minute GIST; Small GIST
Authors: James D Murphy; Grace L Ma; Joel M Baumgartner; Lisa Madlensky; Adam M Burgoyne; Chih-Min Tang; Maria Elena Martinez; Jason K Sicklick Journal: Cancer Date: 2015-04-30 Impact factor: 6.860
Authors: Audrey H Choi; John B Hamner; Shaila J Merchant; Vijay Trisal; Warren Chow; Carlos A Garberoglio; Joseph Kim Journal: J Gastrointest Surg Date: 2015-05-22 Impact factor: 3.452
Authors: Abbas Agaimy; Peter H Wünsch; Ferdinand Hofstaedter; Hagen Blaszyk; Petra Rümmele; Andreas Gaumann; Wolfgang Dietmaier; Arndt Hartmann Journal: Am J Surg Pathol Date: 2007-01 Impact factor: 6.394
Authors: Grace L Ma; James D Murphy; Maria E Martinez; Jason K Sicklick Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-10-02 Impact factor: 4.254
Authors: Klaus Kramer; Uwe Knippschild; Benjamin Mayer; Kira Bögelspacher; Hanno Spatz; Doris Henne-Bruns; Abbas Agaimy; Matthias Schwab; Michael Schmieder Journal: BMC Cancer Date: 2015-02-14 Impact factor: 4.430
Authors: Katherine E Fero; Taylor M Coe; Paul T Fanta; Chih-Min Tang; James D Murphy; Jason K Sicklick Journal: JAMA Surg Date: 2017-05-01 Impact factor: 14.766
Authors: Eleftherios A Makris; Ashwyn K Sharma; Erik N Bergstrom; Xiaojun Xu; Jorge de la Torre; Sudeep Banerjee; Vi Nguyen; Mojgan Hosseini; Adam Burgoyne; Olivier Harismendy; Ludmil B Alexandrov; Jason K Sicklick Journal: JCO Precis Oncol Date: 2021-03-19
Authors: Rebecca Zhu; Fangfang Liu; Gabriella Grisotti; Javier Pérez-Irizarry; Charles H Cha; Caroline H Johnson; Daniel J Boffa; Dale Han; Kimberly L Johung; Yawei Zhang; Sajid A Khan Journal: J Gastrointest Oncol Date: 2018-04